| NCT ID | NCT04880590 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundación Santiago Dexeus Font |
| Condition | Infertility, Female |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,500 participants |
| Start Date | 2021-05-04 |
| Primary Completion | 2025-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,500 participants in total. It began in 2021-05-04 with a primary completion date of 2025-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the impact of sexual intercourse and orgasm in the 72 hrs following embryo transfer of blastocysts on the clinical pregnancy rate. An impact on sexual activity and a decrease in the frequency of intercourse has been observed in infertile couples. In couples who undergo assisted reproductive technology (ART), sexual relations have an additional component that can condition them, such as the fear of influencing the outcome of the cycle. The usual practice in ART cycles has evolved towards a preference for blastocyst-stage embryo transfer, both in fresh in vitro fertilization (IVF) cycles and in frozen embryo transfer (FET) cycles. The investigators consider it important to elucidate whether coital intercourse after embryo transfer (ET) has an impact on the clinical pregnancy rate after the transfer of blastocyst-stage embryos.
Eligibility Criteria
Inclusion Criteria: * Women with a heterosexual sexual relationship * That they carry out an embryo transfer, in a FET cycle Exclusion Criteria: * Exclusion criteria are not foreseen
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04880590 clinical trial?
This trial is open to female participants only, studying Infertility, Female. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04880590 currently recruiting?
Yes, NCT04880590 is actively recruiting participants. Contact the research team at isagon@dexeus.com for enrollment information.
Where is the NCT04880590 trial being conducted?
This trial is being conducted at Barcelona, Spain.
Who is sponsoring the NCT04880590 clinical trial?
NCT04880590 is sponsored by Fundación Santiago Dexeus Font. The trial plans to enroll 2,500 participants.